Fatigue in bone: a novel phenomenon attributable to bisphosphonate use
- PMID: 19796720
- DOI: 10.1016/j.bone.2009.09.026
Fatigue in bone: a novel phenomenon attributable to bisphosphonate use
Comment in
-
Reply to: fatigue in bone: a novel phenomenon attributable to bisphosphonate use.Bone. 2010 Aug;47(2):455. doi: 10.1016/j.bone.2010.04.603. Epub 2010 May 4. Bone. 2010. PMID: 20447474 No abstract available.
Comment on
-
Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?Bone. 2009 Nov;45(5):843-52. doi: 10.1016/j.bone.2009.07.011. Epub 2009 Jul 22. Bone. 2009. PMID: 19631301
Similar articles
-
Reply to: fatigue in bone: a novel phenomenon attributable to bisphosphonate use.Bone. 2010 Aug;47(2):455. doi: 10.1016/j.bone.2010.04.603. Epub 2010 May 4. Bone. 2010. PMID: 20447474 No abstract available.
-
Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw.Am J Otolaryngol. 2010 Mar-Apr;31(2):127-9. doi: 10.1016/j.amjoto.2008.11.002. Epub 2009 Mar 26. Am J Otolaryngol. 2010. PMID: 20015718
-
Bisphosphonate therapy for cancer and prevalence of inflammatory jaw conditions.J Natl Cancer Inst. 2007 Jul 4;99(13):986-7. doi: 10.1093/jnci/djm029. Epub 2007 Jun 27. J Natl Cancer Inst. 2007. PMID: 17596571 No abstract available.
-
Bisphosphonate-related osteonecrosis of the jaw presenting as a cutaneous dental sinus tract: a case report and review of the literature.J Am Acad Dermatol. 2010 Apr;62(4):672-6. doi: 10.1016/j.jaad.2008.09.021. Epub 2010 Feb 11. J Am Acad Dermatol. 2010. PMID: 20153079 Review.
-
Alveolar bone and the bisphosphonates.Aust Dent J. 2009 Sep;54 Suppl 1:S51-61. doi: 10.1111/j.1834-7819.2009.01143.x. Aust Dent J. 2009. PMID: 19737268 Review.
Cited by
-
Changes in peripheral monocyte populations 48-72 hours after subcutaneous denosumab administration in women with osteoporosis.J Musculoskelet Neuronal Interact. 2020 Sep 1;20(3):339-346. J Musculoskelet Neuronal Interact. 2020. PMID: 32877971 Free PMC article.
-
The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.J Osteoporos. 2011 Feb 16;2011:147689. doi: 10.4061/2011/147689. J Osteoporos. 2011. PMID: 21403823 Free PMC article.
-
Increased CD14+ and decreased CD14- populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients.Osteoporos Int. 2017 Mar;28(3):991-999. doi: 10.1007/s00198-016-3807-0. Epub 2016 Nov 17. Osteoporos Int. 2017. PMID: 27858122
-
Epidemiology and pathogenesis of osteonecrosis of the jaw.Nat Rev Rheumatol. 2011 Nov 29;8(2):90-6. doi: 10.1038/nrrheum.2011.181. Nat Rev Rheumatol. 2011. PMID: 22124271 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources